<DOC>
	<DOCNO>NCT00041561</DOCNO>
	<brief_summary>The purpose study determine effect nitric oxide inhalation duration mechanical ventilation pediatric patient AHRF .</brief_summary>
	<brief_title>Effects Inhaled Nitric Oxide Treatment Acute Hypoxemic Respiratory Failure ( AHRF ) Pediatrics</brief_title>
	<detailed_description>Patients receive 5-ppm study gas ( nitric oxide inhalation placebo ) Day 28 extubation , whichever come first . The follow perform / record specify time study : arterial blood gas , ventilator setting , methemoglobin , PRISM III score , patient positioning . Selected center also perform plasma cytokine assay , broncho-alveolar lavage fluid assay 6 month follow-up assessment .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Inclusion criterion : Admitted pediatric intensive care unit diagnosis acute respiratory failure 44 week post conceptional age 16 year age Oxygenation Index ( OI ) &gt; =12 cm H2O/mmHg ( determine two separate measurement take 30 minute 4 hour apart ) Recent chest xray ( within 24 hour ) show least unilateral infiltration Mechanically ventilate &lt; = 7 day Exclusion criterion : Immunocompromised Received bone marrow transplant Active oncological condition Persistent right leave intracardiac shunt Cardiovascular surgery within last 14 day Status asthmaticus Decision primary care physician provide full support Received treatment nitric oxide inhalation investigational medication within 24 hour prior study initiation , participate surfactant trial Chronically ventilate Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Acute hypoxemic respiratory failure</keyword>
</DOC>